Chinese DRAM maker ChangXin plans a Shanghai IPO, sources say after US chip toolmakers assured the equipment the company needs is exempt from export controls
Context & Ripple Effects
This FT report opened what became a years-long listing saga: ChangXin's Shanghai float, floated here on the back of US toolmakers assuring the company its needed equipment sits outside export controls, was subsequently shelved when ChangXin delayed the IPO to wait out weak markets, then revived at steadily larger sizes as Beijing kept backing it — including a $1.99B Big Fund injection into subsidiary Changxin Xinqiao worth about a third of that unit's registered capital.
Why it matters: the story pairs two levers — foreign tools still flowing under an exemption carve-out, and domestic capital replacing foreign markets for sanctioned Chinese chip firms. It follows the template set weeks earlier when the SMIC-backed Shaoxing venture filed to raise ~$1.4B on Shanghai's STAR Market 'as Beijing battles US tech curbs.'
First-order effects
- US chip toolmakers keep a live revenue channel into Chinese memory: the reported exemption assurance means ChangXin can buy the kit it needs and proceed toward listing without a supply overhang hanging over its prospectus.
- ChangXin gains a domestic fundraising path on Shanghai's chip-heavy STAR Board, joining the same venue the SMIC-backed Shaoxing venture chose for its own ~$1.4B raise.
Second-order effects
- State capital crowds in around the float rather than waiting for it — the Big Fund's 33.15% stake in Changxin Xinqiao shows public money de-risking the buildout ahead of the public raise, a pattern other Chinese chip issuers can follow onto the STAR Board.
- The exemption carve-out blunts the intended bite of US controls: if memory-grade tools stay exempt while logic tools are restricted, toolmakers face pressure to qualify more of their lines for similar carve-outs to defend China revenue.
Third-order effects
- If the pattern holds, export controls reroute rather than stop Chinese memory expansion: later filings show CXMT reaching a 4% global DRAM share, upsizing the IPO repeatedly, and targeting HBM output — a bifurcating memory market where Chinese capacity grows largely on Western tools bought under carve-outs and funded by Shanghai listings.
The trend: China's chip champions are financing capacity buildouts through ever-larger Shanghai listings while export-control carve-outs keep US toolmakers' China revenue flowing.